Comparison Chart Cardiol Therapeutics Inc.

Stocks

CRDL

CA14161Y2006

Biotechnology & Medical Research

Delayed Toronto S.E. 16:00:00 2026-10-15 EDT			5-day change	1st Jan Change
1.600 ^CAD	0.00%		-13.51%	+22.14%

09-23	Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead of Schedule and Expands Pivotal Trial	CI
09-23	Cardiol Therapeutics Inc. Achieves MAVERIC Enrollment Target And Expands Pivotal Trial Evaluating CardiolRx	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	CARDIOL THERAPEUTICS INC.	Other Biotechnology & Medical Research	0.00%	-13.51%	+22.14%	+4.58%	-67.01%	132M